Talk:B-cell maturation antigen
Jump to navigation
Jump to search
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
 | The contents of the ALLO-715 page were merged into B-cell maturation antigen on 8 February 2023. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
| ALLO-715 was nominated for deletion. The discussion was closed on 30 May 2022 with a consensus to merge. Its contents were merged into B-cell maturation antigen. The original page is now a redirect to this page. For the contribution history and old versions of the redirected article, please see its history; for its talk page, see here. |
Could mention
It is an experimental T-cell therapy target - for MM. [1] - Rod57 (talk) 15:41, 25 March 2017 (UTC)